Curia Executive and Leadership Team

Philip Macnabb, the Chief Executive Officer at Curia, directs the overarching corporate strategy and long-term vision for the organization. Overseeing global operations, the Chief Executive Officer ensures alignment between R&D capabilities and commercial manufacturing requirements for biopharmaceutical clients. This leadership role involves driving expansion across international markets while maintaining rigorous quality standards in pharmaceutical production. By optimizing resource allocation, Philip Macnabb directly impacts the company's ability to scale complex drug development projects. Ultimately, Macnabb secures the competitive positioning of the firm within the highly regulated life sciences sector, fostering growth through strategic partnerships and technological investment. The Chief Executive Officer maintains constant communication with the Board to ensure financial health and operational efficiency across all business units, consistently pushing the boundaries of contract research services to meet evolving industry demands.

James Grabowski, the President, Research & Development at Curia, directs the scientific strategy and laboratory operations for the organization. Overseeing the transition of molecules from early-stage discovery to clinical development, the President, Research & Development ensures that scientific methodologies meet the rigorous requirements of pharmaceutical clients. This leadership role involves managing high-performing research teams and optimizing laboratory throughput to accelerate project timelines. By integrating advanced chemical and biological expertise, James Grabowski directly impacts the success rate of drug development programs. Ultimately, Grabowski drives innovation in service offerings, ensuring that the company remains a preferred partner for complex R&D challenges. The President, Research & Development collaborates with commercial teams to align scientific capabilities with market needs, ensuring that the organization delivers high-quality, actionable data to support the advancement of new therapeutic candidates.

Kourtney Forster, the President at Curia, directs the execution of business unit objectives and operational performance across the organization. Overseeing the integration of service lines, the President ensures that internal processes support the delivery of high-quality products to biopharmaceutical customers. This leadership role involves managing cross-functional teams to improve operational efficiency and client satisfaction. By refining business processes, Kourtney Forster directly impacts the profitability and scalability of the company's service portfolio. Ultimately, Forster drives the implementation of strategic initiatives that enhance the firm's market position in the contract manufacturing sector. The President works closely with the executive team to monitor performance metrics and adjust operational strategies in response to market shifts, ensuring that the organization consistently meets the complex demands of its global client base through disciplined execution and process optimization.

Ronald Aungst, the President, Drug Product at Curia, directs the commercial manufacturing operations for finished dosage forms. Overseeing the production facilities and supply chain logistics, the President, Drug Product ensures that all manufacturing activities adhere to strict quality and regulatory standards. This leadership role involves managing the scale-up of drug products from pilot batches to full-scale commercial production. By optimizing manufacturing workflows, Ronald Aungst directly impacts the reliability and cost-effectiveness of the company's drug product services. Ultimately, Aungst drives the expansion of manufacturing capacity to meet the growing needs of biopharmaceutical partners. The President, Drug Product collaborates with quality assurance and engineering teams to maintain operational excellence, ensuring that the company delivers high-quality pharmaceutical products that meet the precise specifications of clients while maintaining compliance with global health authority requirements.

Prakash Pandian, the Chief Information Officer at Curia, architects the digital infrastructure supporting global research and manufacturing workflows. Managing enterprise-wide data security and systems integration, the Chief Information Officer ensures seamless connectivity between laboratory environments and commercial production facilities. This leadership role involves implementing advanced analytics platforms to streamline drug development timelines for pharmaceutical clients. By modernizing legacy systems, Prakash Pandian directly impacts the efficiency of cross-functional teams operating across diverse geographic regions. Ultimately, Pandian drives the digital transformation agenda, enabling secure data exchange and robust intellectual property protection. The Chief Information Officer collaborates with executive leadership to align technology investments with business growth objectives, ensuring that digital tools remain at the forefront of the industry to support complex scientific processes and high-stakes manufacturing requirements.

Joseph Sangregorio, the Chief Human Resources Officer at Curia, directs talent acquisition and organizational development strategies across the global workforce. Overseeing human capital initiatives, the Chief Human Resources Officer ensures the recruitment of top-tier scientific and manufacturing talent to support complex pharmaceutical projects. This leadership role involves designing performance management frameworks that incentivize innovation and operational excellence. By fostering a culture of safety and professional growth, Joseph Sangregorio directly impacts employee retention and organizational productivity. Ultimately, Sangregorio aligns workforce capabilities with the evolving needs of biopharmaceutical customers, ensuring that the company maintains a competitive edge in the labor market. The Chief Human Resources Officer works closely with other executives to implement leadership development programs, ensuring that the organization possesses the necessary expertise to navigate the challenges of the modern drug development landscape.

Gregory Kuzma, the Senior Vice President, Chief Information Officer at Curia, manages the strategic deployment of information technology to optimize manufacturing and supply chain operations. Overseeing the implementation of specialized software for pharmaceutical production, the Senior Vice President, Chief Information Officer ensures compliance with global regulatory standards through robust data governance. This leadership role involves enhancing the digital interface between internal manufacturing teams and external biopharmaceutical partners. By streamlining technical workflows, Gregory Kuzma directly impacts the speed and reliability of commercial manufacturing services. Ultimately, Kuzma drives the adoption of emerging technologies to improve operational transparency and process control. The Senior Vice President, Chief Information Officer coordinates with site leaders to ensure that IT infrastructure supports the unique demands of drug product manufacturing, maintaining high levels of system availability and security across all production facilities.